Navigation Links
Bioniche Reports Fiscal 2008 Third Quarter
Date:5/9/2008

# $ $ $

-------------------------------------------------------------------------

Balance, June 30,

2006 12,000,000 11,731,716 - 4,556,290

Net loss for the

period - - - -

Issued under

employee share

ownership plan - - - 8,978

Stock-based

compensation - - - 166,264

Shares issued to

directors - - - -

Share bonus - - - -

Shares issued on

exercise of options - - - (89)

Term debt repayment

made in shares - - - (79,571)

Warrants issued in

connection with

the convertible

term note - - - 93,023

Revolving debt

principal payments

made in shares - - - -

Unit offering, net

of issue costs - - 2,159,568 775,833

-------------------------------------------------------------------------

Balance, March 31,

2007 12,000,000 11,731,716 2,159,568 5,520,728

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Balance, June 30,

2007 9,000,000 8,798,787 2,174,008 5,528,059

Transition

adjustment - - - -

Net loss for the

period - - - -

Issued under

employee sha
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Bioniche Appoints U.S. President of Food Safety
2. Bioniche Reports the Passing of its Board Chair
3. Bioniche Converts a Portion of its Debt to Equity
4. Bioniche Receives Fast Track Designation For First-Line Bladder Cancer Therapy
5. Bioniche Pharma Chooses TrackWise for its Deviation Control Solution
6. Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
7. Bioniche Reports Fiscal 2008 Second Quarter
8. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
9. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
10. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
11. Bioniche Reports Fiscal 2008 First Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2008)...cilities, Caregivers Call for Better Care,Better ...wswire/ -- Families visiting their,loved ones at m... states,across the nation this Mother,s Day will r...ty care advocates. The effort asks family members ...avid Rubenstein to demand better,care. In addition...
(Date:5/10/2008)...with Efforts to Gain Clearance for Airlift of ..., Conn., May 10 /PRNewswire-USNewswire/ -- An Amer...earlier today to assess the,crisis situation and c...rganization,s airlift of 15 tons of essential medi...s is working closely with the World Health Organiz...
(Date:5/10/2008)...smart to avoid devastating vision injuries, group ...s) -- Every year in the United States, about 40,00...the American Academy of Ophthalmology (AAO), which...orts-specific eye protection properly fitted by an...carbonate materials offer the highest level of imp...
(Date:5/9/2008)...in may provide protection against heart disease ...GTON, Va., May 8 /PRNewswire/ -- Brown rice, a 100...nks of healthful whole grains, according,to an ann...ministration,(FDA) that will allow brown rice food... will enable consumers to easily identify brown ri...
Breaking Medicine News(10 mins):Health News:Advocates Make Mother's Day Push for Quality Care 2Health News:AmeriCares Relief Worker Arrives in Myanmar 2Health News:Protective Eyewear Key to Sports Safety 2Health News:FDA Approves Health Claim for Brown Rice 2Health News:FDA Approves Health Claim for Brown Rice 3Health News:FDA Approves Health Claim for Brown Rice 4Health News:FDA Approves Health Claim for Brown Rice 5
...4 lives in Meghalaya's Garo Hills region bordering...nister E D Marak told the assembly today//. Repl...uri (IND), Marak said the death toll in Garo Hills...24 deaths were reported till June. Assam reported ...
... study conducted by the researchers at the Imperia...fer from fewer allergic responses than the others/...in animals prevent asthma and allergies. It was fo...led research rodents had fewer allergic reactions ...
...ch conducted by Dr. Bing-Huei Chen and colleagues ... unhealthy cholesterol //compounds that form durin...iversity in Taipei, Taiwan. Cholesterol Oxidation ...erol-rich foods are processed or heated in excess....
...oken up after a stroke to find that her Geordie ac...ois kind of accent//. Lynda Walker, 60, is the vi...th a different accent. She regained consciousness ...year to find that she had lost her strong Geordie ...
Other Medicine News:
(Date:5/9/2008)...ied in Patients Following Bunionectomy,, TAMPA...-surgery,patients experience intense pain for seve... most common foot surgeries. The investigational p...ief for patients who had this,surgery, compared to...adol,also resulted in patients reporting fewer gas...
(Date:5/8/2008)...search Network Completes 13 Phase-I Clinical Tri...e Development, EL SEGUNDO, Calif., May 8 /PRNewsw... I-IV clinical trial research service business spe...h and development for FDA approval,reports it com...another 34,active trials in late stage drug develo...
(Date:5/8/2008)...port potential of asenapine in the treatment of ...r, WASHINGTON, May 8 /- Sc...unced that an overview of asenapine clinical trial...1st Annual Meeting of the,American Psychiatric Ass...he studies, involving patients with bipolar I diso...
(Date:5/8/2008)...th Annual Meeting of the American Pain Society ...May 8 /- Patients treated with lacosa...tic neuropathic pain (DNP),compared to placebo-tr...,27th annual meeting of the American Pain Society ...controlled trial of a diabetic neuropathic,pain tr...
Breaking Medicine Technology:New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 4New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 5DaVita Clinical Research Completes Record Number of Renal Trials in 2007 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 2New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 4AIDS interferes with stem cells in the brain 60 1AIDS interferes with stem cells in the brain 60 2AIDS interferes with stem cells in the brain 60 3Scientists link fragile X tremor ataxia syndrome to binding protein in RNA 56 1Scientists link fragile X tremor ataxia syndrome to binding protein in RNA 56 2Adaptation to parasites drive African fishes along different evolutionary paths 52 1Adaptation to parasites drive African fishes along different evolutionary paths 52 2Conquest of land began in shark genome 48 1Conquest of land began in shark genome 48 2Conquest of land began in shark genome 48 3
...e-FirstCall/ -- BSD,Medical Corp. announced today ... III clinical trial testing the benefit of adding,...d at the annual,American Society of Clinical Oncol...s. According to the results of this clinical study...r treatment,institutions and at Duke University Me...
... ASCO -, CHICAGO, June 04, 2007 /PRNewswire-FirstC...TM) (eculizumab), a new treatment for,paroxysmal n...,Pharmaceuticals, Inc. , is effective in patients ...anemia (AA) or myelodysplastic,syndromes (MDS). So...tion (hemolysis), decreased or eliminated blood tr...
Other Medicine Technology:Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival,Compared to Chemotherapy Alone for Sarcoma Cancer Patients 2Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival,Compared to Chemotherapy Alone for Sarcoma Cancer Patients 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 2Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 5Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 6Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 7
Set of six replacement burrs for E0824 Storz corneal burr set. Dull finish. Most popular size or model.
Battery operated single speed motorized handpiece, tip cover, supplied with 0.5 mm tungsten burr (E0815 0.5) and one battery size "AA".
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle.
Short 12 mm taper with needle type tip. Stainless steel. Round smooth handle with polished finish. Overall length: 2.8 inches.
Medicine Products: